Trial intelligence / Profile preview

Micro/Nanobubbles for Wound Therapy

NCT05169814Phase 1Recruiting

Sponsor
University of California, Irvine
Start
Oct 2021
Primary completion
Jun 2026
Modality
Device-based Delivery
Countries
1
01

Overview

Phase 1, randomised trial of Micro/nanobubbles in acute wound and Chronic wound (4 arms), sponsored by University of California, Irvine. Primary endpoints: Wound total oxygen saturation level, Wound Size/ Surface Area and 18 more. Started Oct 2021; status: recruiting.

02

Drugs

Micro/nanobubbles
03

Conditions

acute woundChronic wound

Beyond the preview

Go deeper on NCT05169814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05169814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call